Myricetin is a novel inhibitor of human inosine 5′-monophosphate dehydrogenase with anti-leukemia activity
-
Add time:09/25/2019 Source:sciencedirect.com
Human inosine 5′-monophosphate dehydrogenase (hIMPDH) is a rate-limiting enzyme in the de novo biosynthetic pathway of purine nucleotides, playing crucial roles in cellular proliferation, differentiation, and transformation. Dysregulation of hIMPDH expression and activity have been found in a variety of human cancers including leukemia. In this study, we found that myricetin, a naturally occurring phytochemical existed in berries, wine and tea, was a novel inhibitor of human type 1 and type 2 IMPDH (hIMPDH1/2) with IC50 values of 6.98 ± 0.22 μM and 4.10 ± 0.14 μM, respectively. Enzyme kinetic analysis using Lineweaver-Burk plot revealed that myricetin is a mix-type inhibitor for hIMPDH1/2. Differential scanning fluorimetry and molecular docking simulation data demonstrate that myricetin is capable of binding with hIMPDH1/2. Myricetin treatment exerts potent anti-proliferative and pro-apoptotic effects on K562 human leukemia cells in a dose-dependent manner. Importantly, cytotoxicity of myricetin on K562 cells were markedly attenuated by exogenous addition of guanosine, a salvage pathway of maintaining intracellular pool of guanine nucleotides. Taking together, these results indicate that natural product myricetin exhibits potent anti-leukemia activity by interfering with purine nucleotides biosynthetic pathway through the suppression of hIMPDH1/2 catalytic activity.
We also recommend Trading Suppliers and Manufacturers of 2'-(5''-phosphoribosyl)-5'-adenosine monophosphate (cas 15720-01-1). Pls Click Website Link as below: cas 15720-01-1 suppliers
Prev:Hydrophilic-interaction liquid chromatography–tandem mass spectrometric determination of erythrocyte 5-phosphoribosyl 1-pyrophosphate in patients with hypoxanthine–guanine phosphoribosyltransferase deficiency
Next:Novel tetrakis 4-(hydroxymethyl)-2,6-dimethoxyphenoxyl substituted metallophthalocyanines: Synthesis, electrochemical redox, electrocatalytic oxygen reducing, and volatile organic compounds sensing and adsorption properties) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Hydrophilic-interaction liquid chromatography–tandem mass spectrometric determination of erythrocyte 5-phosphoribosyl 1-pyrophosphate in patients with hypoxanthine–guanine phosphoribosyltransferase deficiency09/24/2019
- Orotate phosphoribosyl transferase mRNA expression in oral squamous cell carcinoma and its relationship with the dihydropyrimidine dehydrogenase expression and the clinical effect of 5-fluorouracil09/10/2019
- ReviewOrotidine Monophosphate Decarboxylase – A Fascinating Workhorse Enzyme with Therapeutic Potential09/09/2019
- The formation of a 1–5 phosphodiester linkage in the spontaneous breakdown of 5-phosphoribosyl-α-1-pyrophosphate09/08/2019
- Accumulation of 5-phosphoribosyl-1-pyrophosphate in human CCRF-CEM leukaemia cells treated with antifolates09/07/2019
- BiomarkersInosine Monophosphate Dehydrogenase Pharmacogenetics in Hematopoietic Cell Transplantation Patients09/06/2019
- The catalytic effect of Mg2+ and imidazole on the decomposition of 5-phosphoribosyl-α-1-pyrophosphate in aqueous solution09/05/2019
- Sustainable synthesis of uridine-5′-monophosphate analogues by immobilized uracil phosphoribosyltransferase from Thermus thermophilus09/04/2019
- Carbocyclic phosphonate analogs of 2′,3′-dideoxyadenosine-5′-monophosphate as substrates of 5-phosphoribosyl-1-pyrophosphate (PRPP) synthetate09/03/2019


